Iron Metabolism and Iron Chelation in Sickle Cell Disease

Publisher： Karger

E-ISSN： 1421-9662|122|2-3|174-183

ISSN： 0001-5792

Source： Acta Haematologica, Vol.122, Iss.2-3, 2009-11, pp. : 174-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Deferasirox for iron chelation in multitransfused children with sickle cell disease; long‐term experience in the East London clinical haemoglobinopathy network

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 4, 2015-04 ,pp. : 336-342

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Iron Chelation Therapy on Glucose Metabolism in Non-Transfusion-Dependent Thalassaemia

By  

Acta Haematologica, Vol. 137, Iss. 1, 2016-11 ,pp. : 20-26

Karger

Access to resources Recommend Favorite

Iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions

By  

JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS (ELECTRONIC), Vol. 27, Iss. 10, 2015-10 ,pp. : 591-596

John Wiley & Sons Inc

Access to resources Recommend Favorite

Defective nitric oxide metabolism in sickle cell disease

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 3, 2015-03 ,pp. : 373-374

John Wiley & Sons Inc

Access to resources Recommend Favorite

Iron restriction in sickle cell anemia: Time for controlled clinical studies

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 12, 2015-12 ,pp. : E217-E217

John Wiley & Sons Inc

Access to resources Recommend Favorite